Differential effects of estrogen/androgen on the prevention of nonalcoholic fatty liver disease in the male rat

Journal of Lipid Research

Volumn 54, Issue 2, 2013, Pages 345-357

  Zhang, Hua ^a   Liu, Yuanwu ^a   Wang, Li ^a   Li, Zhen ^a   Zhang, Hongwen ^b   Wu, Jihua ^b   Rahman, Nafis ^c,d   Guo, Yangdong ^a   Li, Defa ^a   Li, Ning ^a   Huhtaniemi, Ilpo ^e   Tsang, SukYing ^f   Gao, George F ^g   Li, Xiangdong ^a  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

^b 306 HOSPITAL OF PLA   (China)

^c UNIVERSITY OF TURKU   (Finland)

^d FLORIDA INTERNATIONAL UNIVERSITY   (United States)

^e IMPERIAL COLLEGE LONDON   (United Kingdom)

^f CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^g INSTITUTE OF MICROBIOLOGY   (China)

Author keywords

Androgen receptor; Estrogen receptor; Lipid metabolism; Nonalcoholic steatohepatitis

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ANDROGEN RECEPTOR; ANDROSTANOLONE; CARNITINE PALMITOYLTRANSFERASE I; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; DRUG MECHANISM; ENZYME PHOSPHORYLATION; FATTY ACID OXIDATION; FATTY ACID SYNTHESIS; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER WEIGHT; MALE; METABOLIC INHIBITION; NONALCOHOLIC FATTY LIVER; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ACETYL-COA CARBOXYLASE; AGED; ANDROGENS; ANIMALS; BODY WEIGHT; CELL LINE; CHOLESTEROL; DIET, HIGH-FAT; DIHYDROTESTOSTERONE; DISEASE PROGRESSION; DOWN-REGULATION; ESTRADIOL; ESTROGENS; FATTY ACIDS; FATTY LIVER; HUMANS; HYDROXYMETHYLGLUTARYL COA REDUCTASES; INTERLEUKIN-1; LIPOGENESIS; LIVER; MALE; MIDDLE AGED; ORCHIECTOMY; ORGAN SIZE; OXIDATION-REDUCTION; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ANDROGEN; RECEPTORS, ESTROGEN; SIGNAL TRANSDUCTION; TESTOSTERONE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84872442941     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M028969     Document Type: Article

References (38)

1. Cheung, O., A. Kapoor, P. Puri, S. Sistrun, V. A. Luketic, C. C. Sargeant, M. J. Contos, M. L. Shiffman, R. T. Stravitz, R. K. Sterling, et al. 2007. The impact of fat distribution on the severity of nonalcoholic fatty liver disease and metabolic syndrome. Hepatology. 46: 1091-1100. (Pubitemid 350144773)
2. Sanyal, A. J. 2002. AGA technical review on nonalcoholic fatty liver disease. Gastroenterology. 123: 1705-1725. (Pubitemid 35231670)
3. Hewitt, K. N., K. Pratis, M. E. Jones, and E. R. Simpson. 2004. Estrogen replacement reverses the hepatic steatosis phenotype in the male aromatase knockout mouse. Endocrinology. 145: 1842-1848. (Pubitemid 38402393)
4. Jones, M. E., A. Thorburn, and K. Britt. 2000. Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity. Proc. Natl. Acad. Sci. USA. 97: 12735-12740.
5. Murata, Y., Y. Ogawa, T. Saibara, A. Nishioka, Y. Fujiwara, M. Fukumoto, T. Inomata, H. Enzan, S. Onishi, and S. Yoshida. 2000. Unrecognized hepatic steatosis and non-alcoholic steatohepatitis in adjuvant tamoxifen for breast cancer patients. Oncol. Rep. 7: 1299-1304.
6. Carani, C., K. Qin, M. Simoni, M. Faustini-Fustini, S. Serpente, J. Boyd, K. S. Korach, and E. R. Simpson. 1997. Effect of testosterone and estradiol in a man with aromatase deficiency. N. Engl. J. Med. 337: 91-95. (Pubitemid 27284394)
7. Smith, E. P., J. Boyd, G. R. Frank, H. Takahashi, R. M. Cohen, B. Specker, T. C. Williams, D. B. Lubahn, and K. S. Korach. 1994. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N. Engl. J. Med. 331: 1056-1061. (Pubitemid 24317698)
8. Maffei, L. 2004. Dysmetabolic syndrome in a man with a novel mutation of the aromatase gene: effects of testosterone, alendronate, and estradiol treatment. J. Clin. Endocrinol. Metab. 89: 61-70. (Pubitemid 38183860)
9. Lubahn, D. B., J. S. Moyer, T. S. Golding, J. F. Couse, K. S. Korach, and O. Smithies. 1993. Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. Proc. Natl. Acad. Sci. USA. 90: 11162-11166. (Pubitemid 23354389)
10. Couse, J. F., S. C. Hewitt, D. O. Bunch, M. Sar, V. R. Walker, B. J. Davis, and K. S. Korach. 1999. Postnatal sex reversal of the ovaries in mice lacking estrogen receptors alpha and beta. Science. 286: 2328-2331. (Pubitemid 30016891)
11. Lemieux, C., D. Phaneuf, F. Labrie, V. Giguere, D. Richard, and Y. Deshaies. 2005. Estrogen receptor alpha-mediated adipositylowering and hypocholesterolemic actions of the selective estrogen receptor modulator acolbifene. Int J Obes (Lond). 29: 1236-1244. (Pubitemid 43080303)
12. Boyanov, M. A., Z. Boneva, and V. G. Christov. 2003. Testosterone supplementation in men with type 2 diabetes, visceral obesity and partial androgen deficiency. Aging Male. 6: 1-7. (Pubitemid 36606394)
13. Kapoor, D., E. Goodwin, K. S. Channer, and T. H. Jones. 2006. Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes. Eur. J. Endocrinol. 154: 899-906. (Pubitemid 43997730)
14. Haider, A., L. J. Gooren, P. Padungtod, and F. Saad. 2010. Improvement of the metabolic syndrome and of non-alcoholic liver steatosis upon treatment of hypogonadal elderly men with parenteral testosterone undecanoate. Exp. Clin. Endocrinol. Diabetes. 118: 167-171.
15. Fan, W., T. Yanase, M. Nomura, T. Okabe, K. Goto, T. Sato, H. Kawano, S. Kato, and H. Nawata. 2005. Androgen receptor null male mice develop late-onset obesity caused by decreased energy expenditure and lipolytic activity but show normal insulin sensitivity with high adiponectin secretion. Diabetes. 54: 1000-1008. (Pubitemid 40450323)
16. Sato, T., T. Matsumoto, T. Yamada, T. Watanabe, H. Kawano, and S. Kato. 2003. Late onset of obesity in male androgen receptor-deficient (AR KO) mice. Biochem. Biophys. Res. Commun. 300: 167-171. (Pubitemid 36042946)
17. Lin, H. Y., I. C. Yu, R. S. Wang, Y. T. Chen, N. C. Liu, S. Altuwaijri, C. L. Hsu, W. L. Ma, J. Jokinen, J. D. Sparks, et al. 2008. Increased hepatic steatosis and insulin resistance in mice lacking hepatic androgen receptor. Hepatology. 47: 1924-1935. (Pubitemid 351945560)
18. Alexandersen, P., and C. Christiansen. 2004. The aging male: testosterone deficiency and testosterone replacement. An up-date. Atherosclerosis. 173: 157-169. (Pubitemid 38488740)
19. Simpson, E. R., M. E. Jones, and C. Clyne. 2006. Lessons from the ArKO mouse. In Aromatase inhibitors. B. J. A. Furr, editor. Birkhäuser Verlag, Switzerland. 139-155.
20. Couse, J. F., and K. S. Korach. 1999. Estrogen receptor null mice: what have we learned and where will they lead us? Endocr. Rev. 20: 358-417. (Pubitemid 30654784)
21. Walters, K. A., K. J. McTavish, M. G. Seneviratne, M. Jimenez, A. C. McMahon, C. M. Allan, L. A. Salamonsen, and D. J. Handelsman. 2009. Subfertile female androgen receptor knockout mice exhibit defects in neuroendocrine signaling, intraovarian function, and uterine development but not uterine function. Endocrinology. 150: 3274-3282.
22. Dieudonne, M. N., R. Pecquery, A. Boumediene, M. C. Leneveu, and Y. Giudicelli. 1998. Androgen receptors in human preadipocytes and adipocytes: regional specificities and regulation by sex steroids. Am. J. Physiol. 274: C1645-C1652.
23. Walters, K. A., U. Simanainen, and D. J. Handelsman. 2010. Molecular insights into androgen actions in male and female reproductive function from androgen receptor knockout models. Hum. Reprod. Update. 16: 543-558.
24. Mu, Y., R. She, H. Zhang, B. Dong, C. Huang, W. Lin, D. Li, and X. Li. 2009. Effects of estrogen and androgen deprivation on the progression of non-alcoholic steatohepatitis (NASH) in male Sprague-Dawley rats. Hepatol. Res. 39: 910-920.
25. Moverare-Skrtic, S., K. Venken, N. Andersson, M. K. Lindberg, J. Svensson, C. Swanson, D. Vanderschueren, J. Oscarsson, J. A. Gustafsson, and C. Ohlsson. 2006. Dihydrotestosterone treatment results in obesity and altered lipid metabolism in orchidectomized mice. Obesity (Silver Spring). 14: 662-672. (Pubitemid 46219741)
26. Foley, J. F., J. B. Collins, D. M. Umbach, S. Grissom, G. A. Boorman, and A. N. Heinloth. 2006. Optimal sampling of rat liver tissue for toxicogenomic studies. Toxicol. Pathol. 34: 795-801.
27. Colnot, S., and C. Perret. 2011. Liver zonation. In Molecular pathology of liver diseases, molecular pathology library 5. Satdarshan P. S. Monga, editor. Springer, New York, Dordrecht, Heidelberg, London. 7-16.
28. Li, X., E. Nokkala, W. Yan, T. Streng, N. Saarinen, A. Warri, I. Huhtaniemi, R. Santti, S. Makela, and M. Poutanen. 2001. Altered structure and function of reproductive organs in transgenic male mice overexpressing human aromatase. Endocrinology. 142: 2435-2442. (Pubitemid 32475760)
29. Shen, Z. J., Y. L. Lu, Z. D. Chen, F. Chen, and Z. Chen. 2000. Effects of androgen and ageing on gene expression of vasoactive intestinal polypeptide in rat corpus cavernosum. BJU Int. 86: 133-137. (Pubitemid 30420778)
30. Sambrook, J., and D. Russel. 2001. Molecular cloning: a laboratory manual, 3rd ed. Cold Spring Harbor Laboratory Press, Woodbury, NY.
31. Li, X., L. Strauss, A. Kaatrasalo, A. Mayerhofer, I. Huhtaniemi, R. Santti, S. Makela, and M. Poutanen. 2006. Transgenic mice expressing p450 aromatase as a model for male infertility associated with chronic inflammation in the testis. Endocrinology. 147: 1271-1277. (Pubitemid 43244360)
32. Coon, H. G., and M. C. Weiss. 1969. A quantitative comparison of formation of spontaneous and virus-produced viable hybrids. Proc. Natl. Acad. Sci. USA. 62: 852-859.
33. Yecies, J. L., H. H. Zhang, S. Menon, S. Liu, D. Yecies, A. I. Lipovsky, C. Gorgun, D. J. Kwiatkowski, G. S. Hotamisligil, C. H. Lee, et al. 2011. Akt stimulates hepatic SREBP1c and lipogenesis through parallel mTORC1-dependent and independent pathways. Cell Metab. 14: 21-32.
34. Ohlsson, C., N. Hellberg, P. Parini, O. Vidal, M. Bohlooly, M. Rudling, M. Lindberg, M. Warner, B. Angelin, and J. Gustafsson. 2000. Obesity and disturbed lipoprotein profile in estrogen receptor-β-deficient male mice. Biochem. Biophys. Res. Commun. 278: 640-645.
35. Vandenput, L., D. Mellstrom, M. Lorentzon, C. Swanson, M. K. Karlsson, J. Brandberg, L. Lonn, E. Orwoll, U. Smith, F. Labrie, et al. 2007. Androgens and glucuronidated androgen metabolites are associated with metabolic risk factors in men. J. Clin. Endocrinol. Metab. 92: 4130-4137. (Pubitemid 350074722)
36. Kamada, Y., S. Kiso, Y. Yoshida, N. Chatani, T. Kizu, M. Hamano, M. Tsubakio, T. Takemura, H. Ezaki, N. Hayashi, et al. 2011. Estrogen deficiency worsens steatohepatitis in mice fed high-fat and high-cholesterol diet. Am. J. Physiol. Gastrointest. Liver Physiol. 301: G1031-G1043.
37. Cole, L. K., R. L. Jacobs, and D. E. Vance. 2010. Tamoxifen induces triacylglycerol accumulation in the mouse liver by activation of fatty acid synthesis. Hepatology. 52: 1258-1265.
38. Ly, L. P., M. Jimenez, T. N. Zhuang, D. S. Celermajer, A. J. Conway, and D. J. Handelsman. 2001. A double-blind, placebo-controlled, randomized clinical trial of transdermal dihydrotestosterone gel on muscular strength, mobility, and quality of life in older men with partial androgen deficiency. J. Clin. Endocrinol. Metab. 86: 4078-4088. (Pubitemid 32848516)